The evaluation of the Effect of Fingolimod on Fatigue and depression in patients with M.S
Not Applicable
- Conditions
- multiple sclerosis.multiple sclerosis
- Registration Number
- IRCT201407018323N11
- Lead Sponsor
- Deputy of Research and Technology of Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Inclusion Criteria: age 18-50 years; definite M.S confirmed by neurologist with relapsing remitting type; disease must be in remission; at least one month after corticostroid therapy; follow up shouldbe possible and patients must be reachable. exclusion criteria: any underlying pulmonary,hepatic,renal or orthopedic; EDSS score>5.5; during follow up events that affect depression happen to the patients.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue severity. Timepoint: before intervention,3 months after initiation of intervention,6 months after initiation of intervention. Method of measurement: fatigue severity scale.;Degree of depression. Timepoint: before intervention,3 months after initiation of intervention,6 months after initiation of intervention. Method of measurement: beck standard questionare.
- Secondary Outcome Measures
Name Time Method iver enzymes concentrations. Timepoint: Before initiation of study,every month for the first 3 months,then every 3 months so on. Method of measurement: Liver function test.;Lymphositic count. Timepoint: Before initiation of study,every month for the first 3 months,then every 3 months after. Method of measurement: CBD-diff.